# Impact of Patient Support by the Medical Staff on Adherence to Therapy With PegIntron Plus Rebetol (Study P04413)

> **NCT00704964** · — · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 746 (actual)

## Conditions studied

- Hepatitis C
- Chronic Hepatitis C

## Interventions

- **BIOLOGICAL:** PegIntron
- **DRUG:** Rebetol

## Key facts

- **NCT ID:** NCT00704964
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 746 (ACTUAL)
- **Last updated:** 2015-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00704964

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00704964, "Impact of Patient Support by the Medical Staff on Adherence to Therapy With PegIntron Plus Rebetol (Study P04413)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00704964. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*